background
influenza
fluv
human
respiratori
syncyti
hrsv
virus
etiolog
agent
respiratori
infect
caus
signific
morbid
mortal
worldwid
rapid
accur
diagnosi
respiratori
virus
essenti
appropri
patient
manag
molecular
test
best
detect
option
due
high
sensit
specif
seegen
respiratori
panel
allplex
realtim
onestep
rtpcr
assay
simultan
detect
fluav
flubv
hrsva
hrsvb
addit
allow
determin
fluav
subtyp
object
studi
aim
evalu
allplex
rapid
molecular
test
detect
fluav
flubv
hrsva
hrsvb
virus
studi
design
allplex
assay
compar
two
commerci
molecular
assay
prodess
proflu
profast
holog
madison
wi
usa
genexpert
flursv
xc
cepheid
usa
result
allplex
proflu
genexpert
test
show
accuraci
sensit
respect
moreov
allplex
show
fluav
subtyp
sensit
respect
profast
assay
show
sensit
target
three
assay
show
specif
ppv
npv
allplex
prodess
genexpert
respect
conclus
studi
seegen
allplex
assay
show
highli
sensit
specif
suitabl
detect
fluv
hrsv
includ
fluav
subtyp
addit
also
handsontim
save
assay
due
autom
nucleic
acid
extract
pcr
setup
respiratori
panel
allplex
seegen
inc
seoul
http
doi
acut
respiratori
infect
ari
repres
major
threat
public
health
influenza
viru
fluv
human
respiratori
syncyti
viru
hrsv
respiratori
infect
respons
signific
morbid
mortal
pediatr
adult
popul
worldwid
season
fluv
estim
affect
world
popul
age
two
practic
children
estim
infect
least
hrsv
earli
identif
caus
pathogen
essenti
prompt
appropri
patient
manag
furthermor
minim
patient
hospit
stay
risk
complic
well
aim
establish
rapid
implement
isol
control
measur
reduc
nosocomi
transmiss
risk
microbiolog
test
need
precis
rapid
identif
caus
agent
among
techniqu
viral
cultur
isol
antigenbas
assay
wide
use
past
howev
techniqu
low
wide
variabl
sensit
specif
moreov
timeconsum
labourintens
therefor
molecular
test
nowaday
consid
best
detect
choic
demonstr
sensit
specif
techniqu
addit
use
multiplex
pcrbase
method
enabl
rapid
accur
identif
multipl
target
reaction
korea
realtim
onestep
rtpcr
assay
detect
influenza
fluav
influenza
b
flubv
virus
human
respiratori
syncyti
b
virus
hrsva
hrsvb
nasopharyng
swab
nasopharyng
aspir
bronchoalveolar
lavag
singl
tube
base
seegen
technolog
assay
make
possibl
detect
multipl
c
valu
analyt
assay
strengthen
seegen
autom
extract
pcr
setup
platform
microlab
nimbu
ivd
hamilton
nevada
usa
similar
present
studi
diagnost
valu
allplex
kit
evalu
compar
prodess
proflu
profast
holog
madison
usa
genexpert
flu
rsv
xc
cepheid
usa
upper
nasopharyng
aspir
swab
lower
bronchoalveolar
lavag
bronchoaspir
tracheal
aspir
respiratori
tract
specimen
submit
laboratori
routin
test
season
use
clinic
evalu
hospit
routin
test
specimen
process
within
first
h
either
immunochromatographi
binax
rsv
card
aller
scarborough
inc
usa
immunofluoresc
ultra
dfa
respiratori
viru
screen
identif
kit
diagnost
hybrid
usa
realtim
multiplex
rtpcr
anyplex
ii
detect
kit
seegen
korea
genexpert
flursv
xc
cepheid
usa
assay
depend
clinic
need
case
fluv
hrsv
posit
sampl
two
inhous
realtim
rtpcr
assay
also
perform
determin
fluav
subtyp
hrsv
genet
group
b
sampl
kept
aliquot
use
clinic
evalu
evalu
perform
use
total
sampl
includ
neg
specimen
respiratori
viru
includ
adenoviru
fluav
flubv
parainfluenza
viru
rhinoviru
hrsva
hrsvb
bocaviru
metapneumoviru
coronaviru
enteroviru
laboratoryconfirm
specimen
test
target
flubv
hrsva
hrsvb
accord
manufactur
instruct
seegen
assay
prior
nucleic
acid
na
extract
requir
respiratori
sampl
elut
final
volum
use
autom
extract
protocol
microlab
nimbu
ivd
workstat
also
perform
pcr
setup
realtim
rtpcr
done
biorad
california
usa
platform
subsequ
interpret
seegen
viewer
softwar
holog
assay
na
extract
respiratori
specimen
elut
use
nuclisens
easymag
marci
franc
accord
manufactur
instruct
realtim
rtpcr
done
smartcycl
cepheid
california
usa
platform
cepheid
assay
fulli
integr
autom
sampl
na
extract
target
amplif
detect
sampl
cartridg
sampl
process
parallel
three
respiratori
viru
detect
assay
aim
minim
risk
bia
comparison
addit
analyt
perform
test
done
analyz
repeat
whole
seegen
procedur
therefor
eight
specimen
panel
prepar
mix
na
previous
analyz
sampl
show
differ
ct
titer
target
high
titer
b
low
titer
c
flubv
high
titer
flubv
low
titer
e
hrsva
high
titer
f
hrsva
low
titer
g
high
titer
h
low
titer
day
within
week
reproduc
evalu
perform
two
repeat
panel
order
compar
result
obtain
three
assay
sensit
specif
ppv
npv
calcul
ms
excel
softwar
microsoft
washington
usa
taken
evalu
paramet
institut
review
board
approv
pr
ag
obtain
hospit
universitari
vall
dhebron
clinic
research
ethic
committe
result
obtain
three
detect
method
comparison
summar
tabl
hrsvb
final
genexpert
assay
show
gener
sensit
fluav
flubv
hrsv
group
addit
allplex
profast
sensit
also
compar
fluav
subtyp
wherea
allplex
show
sensit
respect
profast
assay
show
sensit
target
regard
specif
three
assay
show
valu
ppv
three
assay
npv
allplex
prodess
genexpert
respect
moreov
sampl
show
invalid
result
least
one
assay
allplex
invalid
sampl
prodess
invalid
sampl
genexpert
invalid
sampl
could
also
retest
due
insuffici
sampl
volum
therefor
final
includ
statist
analysi
regard
repeat
analysi
varianc
coeffici
cv
rang
minimum
maximum
tabl
molecular
realtim
pcrbase
method
increasingli
use
detect
fluv
hrsv
well
known
na
amplif
test
thought
superior
mani
aspect
sensit
specif
among
paramet
compar
convent
diagnost
techniqu
cell
cultur
antigen
base
assay
howev
addit
variabl
paramet
differ
commerci
kit
avail
market
need
autom
extract
pcr
setup
also
demand
minim
userrel
bias
studi
novel
allplex
assay
compar
proflu
genexpert
assay
detect
fluv
hrsv
profast
determin
fluav
subtyp
term
sensit
accuraci
npv
genexpert
assay
exhibit
highest
result
follow
allplex
assay
moreov
three
studi
assay
show
excel
specif
ppv
valu
import
characterist
allplex
highlight
work
detect
two
differ
target
fluav
singl
reaction
allow
determin
fluav
subtyp
improv
detect
though
profast
assay
show
highest
sensit
valu
allplex
assay
fluav
subtyp
holog
assay
requir
perform
addit
reaction
increas
final
test
cost
addit
import
consid
case
holog
subtyp
sampl
posit
fluav
proflu
test
test
profast
moreov
allplex
contrast
proflu
genexpert
also
provid
inform
regard
genet
group
hrsv
distinguish
group
group
b
avail
assay
provid
inform
excel
option
use
laboratori
sinc
report
relev
epidemiolog
interest
inform
nonetheless
studi
valid
paramet
could
determin
avail
season
laboratoryconfirm
sampl
wellknown
season
circul
worldwid
sinc
season
futur
circul
fluav
subtyp
discard
near
futur
avail
detect
target
particularli
commerci
diagnost
method
might
help
monitor
reemerg
fluv
subtyp
commun
regard
repeat
techniqu
maximum
percentag
cv
found
allplex
less
recommend
cv
food
drug
administr
guidanc
industri
may
case
laboratori
high
number
specimen
test
seegen
allplex
microlab
nimbu
ivd
shown
use
process
sampl
singl
run
includ
na
extract
pcr
setup
whole
procedur
na
extract
result
interpret
last
less
h
per
run
need
min
handson
time
work
autom
process
minimum
handson
time
must
remark
use
highthroughput
laboratori
workflow
minim
human
error
risk
na
contamin
improv
qualiti
control
reduc
laboratoryrel
cost
addit
data
interpret
softwar
seegen
viewer
optim
multiplex
assay
detect
singl
channel
multipl
ct
fluorophor
valu
provid
semiquantit
inform
also
minim
human
error
could
occur
higher
probabl
interpret
fluoresc
curv
case
holog
assay
data
present
studi
show
allplex
highli
sensit
specif
suitabl
assay
fluv
hrsv
detect
type
provid
relev
inform
clinic
patient
manag
also
valuabl
data
epidemiolog
purpos
chanc
sampl
handl
autom
na
extract
pcr
setup
improv
suitabl
routin
analysi
abbrevi
cv
varianc
coeffici
